Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC1187
TNBC
Basal A
17-AAG
HSP90
HSP90
7812.04
uM
4.6730
5.92090
-0.2506 -0.2552 1.7425 0.3049
0.9762
1.0573
HCC1187
TNBC
Basal A
5-DFUR
TYMS
TYMS
10753.143
uM
89.89790
1000.00000
-0.1974 -0.5152 0.2940 0.3648
0.7850
1.4954
HCC1187
TNBC
Basal A
5-FU
TYMS
TYMS
7811.017
uM
12.20530
48.34130
-0.9997 -1.0000 0.7982 1.0316
0.9194
0.3604
HCC1187
TNBC
Basal A
5-FU
TYMS
TYMS
7812.017
uM
505.4030
1000.00000
-0.8283 -0.6532 1.2246 0.3272
0.9679
1.1362
HCC1187
TNBC
Basal A
AG1024
IGF1R
RTK
7433.066
uM
49.0820
39.44790
0.7887 0.3207 4.6933 -0.0151
0.7750
1.0755
HCC1187
TNBC
Basal A
AG1024
IGF1R
RTK
7431.066
uM
inf
6.29190
0.6023 0.6021 4.9962 0.0616
0.9181
1.1865
HCC1187
TNBC
Basal A
AG1024
IGF1R
RTK
7432.066
uM
inf
6.60440
0.6582 0.6581 5.0000 0.0190
0.9284
0.9987
HCC1187
TNBC
Basal A
AG1478
EGFR
ErbB
7811.044
uM
inf
inf
0.9811 0.9811 0.0000 0.0159
-0.0256
0.3073
HCC1187
TNBC
Basal A
AG1478
EGFR
ErbB
7812.016
uM
inf
0.03633
0.7129 0.7912 4.9997 0.1273
0.8061
1.0628
HCC1187
TNBC
Basal A
AS-252424
PI3K
PI3K
10518.141
uM
1.80660
1.25980
0.1622 0.1140 0.7180 0.2657
0.9263
1.3122
HCC1187
TNBC
Basal A
AS-252424
PI3K
PI3K
10753.153
uM
1.86320
2.3770
0.0840 -0.0820 0.6233 0.2388
0.9612
1.3879
HCC1187
TNBC
Basal A
Baicalein
Lipoxygenase
Metabolism
7431.072
uM
62.80280
6.10020
0.4573 0.4206 0.7892 0.1453
0.9353
1.4372
HCC1187
TNBC
Basal A
Baicalein
Lipoxygenase
Metabolism
10518.072
uM
8.05840
44.66590
-0.4627 -1.0000 0.6415 0.3266
0.9675
1.2152
HCC1187
TNBC
Basal A
Baicalein
Lipoxygenase
Metabolism
10753.072
uM
12.25950
39.21030
-0.6332 -1.0000 0.9449 0.3036
0.9852
1.3367
HCC1187
TNBC
Basal A
Bortezomib
Proteasome
Proteasome
15300.203
uM
0.00104
0.00168
-0.9901 -0.9929 2.2895 1.6434
0.9968
0.8443
HCC1187
TNBC
Basal A
Bortezomib
Proteasome
Proteasome
15300.203
uM
0.00104
0.00168
-0.9901 -0.9929 2.2895 1.6434
0.9968
0.8443
HCC1187
TNBC
Basal A
Bortezomib
Proteasome
Proteasome
7431.074
uM
0.03153
0.04619
-0.9365 -0.9373 2.7635 1.2473
0.9990
1.4349
HCC1187
TNBC
Basal A
Bortezomib
Proteasome
Proteasome
7431.074
uM
0.03153
0.04619
-0.9365 -0.9373 2.7635 1.2473
0.9990
1.4349
HCC1187
TNBC
Basal A
Bortezomib
Proteasome
Proteasome
7432.074
uM
0.01535
0.02166
-0.9993 -0.9985 3.1914 1.3750
0.9993
0.8598
HCC1187
TNBC
Basal A
Bortezomib
Proteasome
Proteasome
7432.074
uM
0.01535
0.02166
-0.9993 -0.9985 3.1914 1.3750
0.9993
0.8598
HCC1187
TNBC
Basal A
Bosutinib
Src
nRTK
10753.145
uM
3.19730
5.23050
-0.3854 -0.4409 1.2844 0.3743
0.9784
1.5180
HCC1187
TNBC
Basal A
Carboplatin
DNA cross-linker
DNA cross-linker
7811.011
uM
9.34130
15.53130
-0.9999 -1.0000 2.1609 0.7396
0.9934
0.4400
HCC1187
TNBC
Basal A
Carboplatin
DNA cross-linker
DNA cross-linker
9244.021
uM
28.070
34.96690
-0.9998 -0.9999 5.0000 0.5650
0.9980
0.4542
HCC1187
TNBC
Basal A
Carboplatin
DNA cross-linker
DNA cross-linker
7812.011
uM
27.99240
39.95870
-0.9731 -0.9495 2.9906 0.5264
0.9987
1.0620
HCC1187
TNBC
Basal A
Celecoxib
COX2
COX
10518.136
uM
inf
inf
0.9091 0.9091 0.0000 0.0220
0.1805
1.2490